Cargando…
Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation
The enhancement of apoptosis is a therapeutic strategy used in the treatment of cancer. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising antitumor agent. However, hepatocellular carcinoma (HCC) cells exhibit marked resistance to the induction of cell death by TRAIL. The...
Autores principales: | LUAN, ZHOU, HE, YING, HE, FAN, CHEN, ZHISHUI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237083/ https://www.ncbi.nlm.nih.gov/pubmed/25333816 http://dx.doi.org/10.3892/mmr.2014.2718 |
Ejemplares similares
-
Cellular FLICE-inhibitory protein is required for T cell survival and cycling
por: Chau, Hien, et al.
Publicado: (2005) -
Activation of autophagy flux by metformin downregulates cellular FLICE–like inhibitory protein and enhances TRAIL- induced apoptosis
por: Nazim, Uddin MD, et al.
Publicado: (2016) -
Immune Escape of Tumors in Vivo by Expression of Cellular Flice-Inhibitory Protein
por: Medema, Jan Paul, et al.
Publicado: (1999) -
Ophiopogonin B sensitizes TRAIL-induced apoptosis through activation of autophagy flux and downregulates cellular FLICE-like inhibitory protein
por: Nazim, Uddin MD., et al.
Publicado: (2017) -
Progress in the Total Synthesis of Rocaglamide
por: Cai, Xiao-hua, et al.
Publicado: (2011)